Eli Lilly Export S.A. Puerto Rico Branch

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$573Kgeneral payments (2019-2025)
$5.6Mresearch payments (2019-2025)
1,310clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $242K
2020 $44K
2021 $95K
2022 $88K
2023 $24K
2024 $47K
2025 $33K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Endocrinology, Diabetes & Metabolism $176K
Hematology & Oncology $139K
Gastroenterology (Internal Medicine) $40K
Dermatology $37K
Internal Medicine $28K
Neurology (Psychiatry & Neurology) $27K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Monica Ortiz-Rivera San Juan, PR Endocrinology, Diabetes & Metabolism $94,011.47
Mirelis Acosta San Juan, PR Hematology & Oncology $23,427.46
Guillermo Valenzuela Plantation, FL $19,483.14
Jose Garcia Mateo Ponce, PR Endocrinology, Diabetes & Metabolism $18,243.73
Martin Dietrich Rockledge, FL Hematology & Oncology $14,843.29
Altagracia Alcantara Gonzalez Bayamon, PR Endocrinology, Diabetes & Metabolism $12,561.51
Michelle Mangual Garcia San Juan, PR Endocrinology, Diabetes & Metabolism $11,775.38
Edgardo Santos Fort Lauderdale, FL Hematology & Oncology $9,450.00
Eric Oliver Baltimore, MD Allergy & Immunology (Internal Medicine) $8,400.00
Javier Alonso-Llamazares Coral Gables, FL Dermatology $8,210.87

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.